176 related articles for article (PubMed ID: 35159053)
1. Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation.
Liu B; Cao Y; Li Y; Ma H; Yang M; Zhang Q; Li G; Zhang K; Wu Y; Zhou Y; Yang W; Sun T
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159053
[TBL] [Abstract][Full Text] [Related]
2. Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.
Anderson AE; Parashar K; Jin K; Clor J; Stagnaro CE; Vani U; Singh J; Chen A; Guan Y; Talukdar P; Sathishkumar P; Juat DJ; Singh H; Kushwaha R; Zhao X; Kaplan A; Seitz L; Walters MJ; Fernandez-Salas E; Walker NPC; Bowman CE
Mol Cancer Ther; 2024 May; ():. PubMed ID: 38797955
[TBL] [Abstract][Full Text] [Related]
3. CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker.
Li C; Zhang L; Jin Q; Jiang H; Wu C
Biomark Med; 2023 Jun; 17(12):563-576. PubMed ID: 37713234
[TBL] [Abstract][Full Text] [Related]
4. SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
Warren MC; Matissek S; Rausch M; Panduro M; Hall RJ; Dulak A; Brennan D; Das Yekkirala S; Koseoglu S; Masia R; Yang Y; Reddy N; Prenovitz R; Strand J; Zaidi T; Devereaux E; Foissac CJ; Stagg J; Lee BH; Holland P; Palombella VJ; Lake AC
Immunohorizons; 2023 May; 7(5):366-379. PubMed ID: 37219538
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39) involved in regulating extracellular ATP-mediated innate immune responses in Japanese flounder (Paralichthys olivaceus).
Li S; Chen X; Wang N; Li J; Feng Y; Sun J
Mol Immunol; 2019 Aug; 112():10-21. PubMed ID: 31075558
[TBL] [Abstract][Full Text] [Related]
6. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
7. Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism.
Spatola BN; Lerner AG; Wong C; Dela Cruz T; Welch M; Fung W; Kovalenko M; Losenkova K; Yegutkin GG; Beers C; Corbin J; Soros VB
MAbs; 2020; 12(1):1838036. PubMed ID: 33146056
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.
Nagate Y; Ezoe S; Fujita J; Okuzaki D; Motooka D; Ishibashi T; Ichii M; Tanimura A; Kurashige M; Morii E; Fukushima T; Suehiro Y; Yokota T; Shibayama H; Oritani K; Kanakura Y
Leukemia; 2021 Jan; 35(1):107-118. PubMed ID: 32203145
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
10. The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
Feng LL; Cai YQ; Zhu MC; Xing LJ; Wang X
Cancer Cell Int; 2020; 20():110. PubMed ID: 32280302
[TBL] [Abstract][Full Text] [Related]
11. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
[TBL] [Abstract][Full Text] [Related]
12. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW
Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862
[TBL] [Abstract][Full Text] [Related]
13. Th2 cytokine-primed airway smooth muscle cells induce mast cell chemotaxis via secretion of ATP.
Gao YD; Cao J; Li P; Huang G; Yang J
J Asthma; 2014 Dec; 51(10):997-1003. PubMed ID: 25272186
[TBL] [Abstract][Full Text] [Related]
14. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
15. Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
Lu JC; Zhang PF; Huang XY; Guo XJ; Gao C; Zeng HY; Zheng YM; Wang SW; Cai JB; Sun QM; Shi YH; Zhou J; Ke AW; Shi GM; Fan J
J Hematol Oncol; 2021 Nov; 14(1):200. PubMed ID: 34838121
[TBL] [Abstract][Full Text] [Related]
16. The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.
d'Almeida SM; Kauffenstein G; Roy C; Basset L; Papargyris L; Henrion D; Catros V; Ifrah N; Descamps P; Croue A; Jeannin P; Grégoire M; Delneste Y; Tabiasco J
Oncoimmunology; 2016 Jul; 5(7):e1178025. PubMed ID: 27622030
[TBL] [Abstract][Full Text] [Related]
17. Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.
Li XY; Moesta AK; Xiao C; Nakamura K; Casey M; Zhang H; Madore J; Lepletier A; Aguilera AR; Sundarrajan A; Jacoberger-Foissac C; Wong C; Dela Cruz T; Welch M; Lerner AG; Spatola BN; Soros VB; Corbin J; Anderson AC; Effern M; Hölzel M; Robson SC; Johnston RL; Waddell N; Smith C; Bald T; Geetha N; Beers C; Teng MWL; Smyth MJ
Cancer Discov; 2019 Dec; 9(12):1754-1773. PubMed ID: 31699796
[TBL] [Abstract][Full Text] [Related]
18. Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation.
Festag J; Thelemann T; Schell M; Raith S; Michel S; Jaschinski F; Klar R
Mol Ther Nucleic Acids; 2020 Sep; 21():656-669. PubMed ID: 32739778
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses.
Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V
Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090
[TBL] [Abstract][Full Text] [Related]
20. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]